EUROPA PASA DE TENER DOS TRATAMIENTOS SCLC-ES EN PRIMERA LINEA INMUNOTERAPIA ( ATEZOLIZUMAB
Y DURVALUMAB ) ... A TENER CUATRO ( ATEZOLIZUMAB, DURVALUMAB , SERPLULIMAB Y TISLELIZUMAB ) .
27 mayo 2020
Jazz Pharmaceuticals Announces Participation at Two Upcoming Virtual Investor Conferences : *.- Jefferies Virtual Healthcare Conference on Wednesday, June 3, 2020 at ... **.- Goldman Sachs Virtual Healthcare Conferenceon Wednesday, June 10, 2020 .